Boston advertises commitment to ensuring defibrillator quality:
This article was originally published in Clinica
Executive Summary
Boston Scientific ran an open letter to customers and patients in US newspaper advertisements last week reassuring them about its commitment to achieving "world-class quality" for its Guidant-acquired line of defibrillators and "clear leadership" in this field. In the letter, company president and CEO James Tobin said he had taken personal responsibility for overseeing the company's defibrillator division and has put a new management team in place. "We are focused on the highest standards of innovation, quality and reliability," he said. "And we have made timely, transparent and responsible communication a requirement."